Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease

Human Mutation

Volumn 9, Issue 2, 1997, Pages 97-109

  Eng, Charis ^a,b   Mulligan, Lois M ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CODON; ENDOCRINE TUMOR; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HIRSCHSPRUNG DISEASE; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; ONCOGENE RET; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIPPLE SYNDROME; SOMATIC MUTATION; THYROID MEDULLARY CARCINOMA;

CARCINOMA, MEDULLARY; DROSOPHILA PROTEINS; ENDOCRINE GLAND NEOPLASMS; GENETIC SCREENING; GERM-LINE MUTATION; HIRSCHSPRUNG DISEASE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; NEUROENDOCRINE TUMORS; PARATHYROID NEOPLASMS; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0030896418     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M     Document Type: Article

References (14)

1. Amiel J, Attié T, Jan D, Pelet A, Edery P, Bidaud C, Lacombe D, Tam P, Simeoni J, Flori E, Nihoul-Fékété C, Munnich A, Lyonnet S (1996) Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet 5:355-357.
2. Angrist M, Kauffman E, Slaugenhaupt SA, Matise RC, Puffenberger EG, Washington SS, Lipson A, Cass DT, Reyna T, Weeks DE, Sieber W, Chakravarti A (1993) A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nature Genet 4:351-356.
3. Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CHCM, Cass DT, Chakravarti A (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4:821-830.
4. Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 3:1613-1619.
5. Attié T, Pelet A, Sarda P, Eng C, Edery P, Mulligan LM, Ponder BAJ, Munnich A, Lyonnet S (1994) A 7 bp deletion of the RET proto-oncogene in familial Hirschsprung's disease. Hum Mol Genet 3:1439-1440.
6. Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, Ponder BAJ, Lyonnet S (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4:1381-1386.
7. Auricchio A, Casari G, Staiano A, Ballabio A (1996) Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from non-inbred population. Hum Mol Genet 5:351-354.
8. Badner JA, Sieber WK, Garver KL, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Hum Genet 46:568-580.
9. Beldjord B, Desclaux-Arramond F, Raffin-Sanson M, Corvol J-C, de Keyser Y, Luton J-P, Plouin P-F, Bertagna X (1995) The RET proto-oncogene in sporadic pheochromocytomas: Frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab 80:2063-2068.
10. Blaugrund JE, Johns MM, Eby YJ, Ball DW, Baylin SB, Hruban RH, Sidransky D (1994) RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet 3:1895-1897.
11. Boccia LM, Green JS, Joyce C, Eng C, Taylor SAM, Mulligan LM (1996) Mutations of RET codon 768 is associated with the FMTC phenotype. Clin Genet.
12. Wells SA, Chi DD, Toshima D, Dehner LP, Coffin CM, Darton B, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H (1994) Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 200:237-250.
13. Zedenius J, Larsson C, Bergholm U, Bovee J, Svensson A, Hallengren B, Grimelius L, Backdahl M, Weber G, Wallin G (1995) Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 80:3088-3090.
14. Zedenius J, Wallin G, Hamberger B, Nordenskjöld M, Weber G, Larsson C (1994) Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTGs. Hum Mol Genet 3:1259-1262.